The county reported its highest detainee death count in decades, including multiple suicides that reveal deep institutional ...
Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and ...
healthday on MSN3h
FDA Approves Cobenfy for Adults With SchizophreniaTHURSDAY, Nov. 14, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback